Dr. Ardem Patapoutian says he watches “with deep sadness as the United States’ remarkable scientific enterprise, which took ...

Study finds enfortumab vedotin + pembrolizumab significantly boosts survival in advanced urothelial carcinoma patients ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...

Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

Enfortumab vedotin plus pembrolizumab in advanced bladder cancer: hint of major added benefit. Patients for whom cisplatin-based therapy is unsuitable live significantly longer with the new drug ...

Matt Galsky, MD, delved into the recent approval of a perioperative durvalumab regimen in muscle-invasive bladder cancer.

At a time when other nations are expanding research and development, the U.S. should be strengthening its commitment, not dismantling it.

Sound Pharmaceuticals is pleased to announce that it has been invited to present its R&D and financing goals at four upcoming ...

Deborah Wong, MD, PhD, discusses the toripalimab combination that is now considered standard of care in nasopharyngeal cancer ...

Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has ...